Results 41 to 50 of about 3,211 (100)
Betten Anne
doaj +1 more source
Bachmann-Stein Andrea
doaj +1 more source
Carelizumab and rivoceranib for advanced extramammary Paget's disease: an investigator-initiated multicenter, single-arm, phase II trial. [PDF]
Zhang S +6 more
europepmc +1 more source
Kabatek Johannes
doaj +1 more source
Enhanced efficacy and long-term survival with SBRT plus PD-1 inhibitors versus SBRT alone in unresectable HCC: a multicenter PSM study. [PDF]
Wei X +10 more
europepmc +1 more source
Pecht Nantke
doaj +1 more source
Hundt Marianne
doaj +1 more source
Antibody-drug conjugate (disitamab vedotin) therapy targeting HER2-low or higher advanced extramammary Paget's disease. [PDF]
Zhang S +8 more
europepmc +1 more source
Schwarz-Friesel Monika
doaj +1 more source

